June 19, 2026 – Patient Worthy

FDA Clears First Over-the-Counter Continuous Glucose Monitor for Children

Post author:Austin Newman
Post published:June 19, 2026
Post category:Diabetes Type 2

As reported on CNET, parents and caregivers now have a new option to help monitor children’s blood sugar levels at home. The US Food and Drug Administration (FDA) has cleared…

FDA Approves Pembrolizumab–Belzutifan Combination for Adjuvant Treatment of High-Risk Clear Cell RCC

Post author:Austin Newman
Post published:June 19, 2026
Post category:Renal Cell Carcinoma

As reported on Pharmaceutical Technology, the US Food and Drug Administration (FDA) has approved a new adjuvant treatment option for adults with clear cell renal cell carcinoma (ccRCC) at elevated…

FDA’s New Framework Signals Turning Point for Rare Disease Therapies—But Major Barriers Remain

Post author:Austin Newman
Post published:June 19, 2026
Post category:Rare Disease

As reported on MedCity News, the U.S. Food and Drug Administration (FDA) has introduced a new regulatory pathway that could reshape how treatments are developed for rare diseases. Known as…

FDA Clears First Over-the-Counter Continuous Glucose Monitor for Children

FDA Approves Pembrolizumab–Belzutifan Combination for Adjuvant Treatment of High-Risk Clear Cell RCC

FDA’s New Framework Signals Turning Point for Rare Disease Therapies—But Major Barriers Remain

Let’s Work Together!

Keep Up to Date

Learn More